Abstract
The World Health Organization’s Classification of Tumours of Haematopoietic and Lymphoid Tissues (Swerdlow et al. (eds) WHO Classification of tumours of haematopoietic and lymphoid tissues, 4th edn. WHO Press, Lyon, 2008) created a classification scheme incorporating genetic, molecular, morphologic, and immunophenotypic characteristics. The diagnosis of acute myeloid leukemia requires equal to or greater than 20% blasts (except in some cases with specific cytogenetic abnormalities or in erythroleukemia). The diagnostic work up typically includes morphologic, cytochemical, and immunophenotypic features. This generally includes evaluation of the peripheral blood, bone marrow aspirate, and bone marrow trephine biopsy. As stated in the WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, “the contribution of an adequate bone marrow biopsy cannot be over stated” (Swerdlow et al. (eds) WHO Classification of tumours of haematopoietic and lymphoid tissues, 4th edn. WHO Press, Lyon, 2008). The evaluation of the bone marrow biopsy provided the necessary material for immunohistochemical studies used for both diagnosis and prognosis.
The following text will focus on the utilization of immunohistochemical studies in the classification of acute myeloid leukemia. Other methodologies will be discussed elsewhere in this volume.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Swerdlow S, Campo E, Harris N et al (eds) (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. WHO Press, Lyon
Rizzatti EG, Garcia AB, Portieres FL et al (2002) Expression of CD117 and CD11b in bone marrow can differentiate acute promyelocytic leukemia from recovering benign myeloid proliferation. Am J Clin Pathol 118(1):31–37
Dunphy CH, O’Malley DP, Perkins SL et al (2007) Analysis of immunohistochemical markers in bone marrow sections to evaluate for myelodysplastic syndromes and acute myeloid leukemias. Appl Immunohistochem Mol Morphol 15(2):154–159
Dunphy CH, Polski JM, Evans HL et al (2001) Evaluation of bone marrow specimens with acute myelogenous leukemia for CD34, CD15, CD117, and myeloperoxidase. Arch Pathol Lab Med 125(8):1063–1069
Lewis RE, Cruse JM, Sanders CM et al (2007) Aberrant expression of T-cell markers in acute myeloid leukemia. Exp Mol Pathol 83(3):462–463
Kang LC, Dunphy CH (2006) Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes. Arch Pathol Lab Med 130(2):153–157
Valbuena JR, Medeiros LJ, Rassidakis GZ et al (2006) Expression of B cell-specific activator protein/PAX5 in acute myeloid leukemia with t(8;21)(q22;q22). Am J Clin Pathol 126(2):235–240
Olsen RJ, Chang CC, Herrick JL et al (2008) Acute leukemia immunohistochemistry: a systematic diagnostic approach. Arch Pathol Lab Med 132(3):462–475
Yang F, Tran TA, Carlson JA et al (2000) Paraffin section immunophenotype of cutaneous and extracutaneous mast cell disease: comparison to other hematopoietic neoplasms. Am J Surg Pathol 24(5):703–709
Dunphy CH (ed) (2015) Integrated Hematopathology: morphology and FCI with IHC, Revised edn. Hong Kong, ASCP Press
Hardy LB, Fitzgibbons PL, Goldsmith JD et al (2013) Immunohistochemistry validation procedures and practices: a College of American Pathologists survey of 727 laboratories. Arch Pathol Lab Med 137(1):19–25
Fitzgibbons PL, Bradley LA, Fatheree LA et al (2014) Principles of analytic validation of immunohistochemical assays: guideline from the College of American Pathologists Pathology and Laboratory Quality Center. Arch Pathol Lab Med 138(11):1432–1443
Prichard JW (2014) Overview of automated immunohistochemistry. Arch Pathol Lab Med 138(12):1578–1582
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Cruise, M.W. (2017). Immunohistochemistry in Acute Myeloid Leukemia. In: Fortina, P., Londin, E., Park, J., Kricka, L. (eds) Acute Myeloid Leukemia. Methods in Molecular Biology, vol 1633. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7142-8_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7142-8_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7140-4
Online ISBN: 978-1-4939-7142-8
eBook Packages: Springer Protocols